ReviewNaunyn-Schmiedeberg's archives of pharmacology2025
Exosomal peptides and proteins in wound healing and skin regeneration.
Review in Naunyn-Schmiedeberg's archives of pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- MSC-derived extracellular vesicles accelerate wound healing in senescent fibroblast cultures.Biogerontology · 2026Article
- Plant Exosome Injection with or without Low Level Laser Therapy Promotes Skin Wound Healing: An Experimental Study.Plastic and reconstructive surgery. Global open · 2026Article
- Human Derived Exosome Injections (ASCE+ vs. CELLEXOSOME) Enhance Collagen Remodeling and Angiogenesis in Intact Skin: A Comparative Experimental Study.Journal of cosmetic dermatology · 2026Article
- Effects of New Cellular Treatment Factor and Human Exosome Injection on Intact Skin Regeneration in a Randomized In Vivo Study.Plastic and reconstructive surgery. Global open · 2026Article
- Acute Lung Injury Induced by Hyperbaric Oxygen or Other External Factors, with a Focus on Exosomes.International journal of molecular sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Wound healing is a highly coordinated biological process that includes inflammation, angiogenesis, proliferation, and tissue remodeling. Chronic wounds, comprising diabetic foot ulcers as well as pressure ulcers, present significant healthcare challenges due to prolonged healing and susceptibility to infections. Traditional treatments often fail to modulate the wound microenvironment, leading to suboptimal outcomes. Recent advancements highlight the potential of exosomal peptides and proteins in enhancing skin regeneration and wound repair. Exosomes are extracellular vesicles released by various cells, containing bioactive molecules like proteins, peptides, growth factors, and microRNAs, which regulate wound healing. Exosomal proteins contribute to angiogenesis by stimulating vascular endothelial growth factor and transforming growth factor-β, while heat shock proteins and matrix metalloproteinases facilitate extracellular matrix remodeling. Exosomal peptides and proteins offer a promising cell-free method for enhancing the healing of wounds and the regeneration of the skin. The present review sheds light on the therapeutic possibilities of exosomal peptides and proteins in wound healing, focusing on their mechanisms, biological effects, clinical applications, and challenges along with their future.
Indexed as
Identifiers
40627201What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.